In addition to its characteristic cytological and architectural features, the lack of metaplastic changes and hormone receptor expression (ER/PR negativity), alongside immunopositivity for GATA3, TTF1, and, more recently, paired box gene 2 (PAX2), helps distinguish MLA from endometrioid carcinoma [121]. This evidence concerns the gene PAX2 and endometrioid adenocarcinoma.